Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3518 publications
Phenex Pharmaceuticals AG - Product Pipeline Review - 2014 US$ 1,500.00

... The report reviews current pipeline of Phenex Pharmaceuticals AG’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Phenex Pharmaceuticals AG’s pipeline products ...

Sep, 2014 27 pages
Global Gene Therapy Market Outlook 2018 US$ 1,500.00

... to boost the growth. According to RNCOS’ new research report “Global Gene Therapy Market Outlook 2018”, a major focus has been on the ongoing ... . Finally, with a view to understanding the competitive landscape, the profiles of key market players have been included in the report to present a complete picture of ...

Sep, 2014 125 pages
SomaGenics Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the SomaGenics Inc.’s pipeline products ... drug targets and therapeutic classes in the SomaGenics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 21 pages
Medeia Therapeutics Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Medeia Therapeutics Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Medeia Therapeutics Ltd.’s pipeline products Reasons to ...

Aug, 2014 25 pages
Mabion SA - Product Pipeline Review - 2014 US$ 1,500.00

... - 2014 Summary Global Markets Direct’s, ‘Mabion SA - Product Pipeline Review - 2014’, provides an overview of the Mabion SA’s pharmaceutical research and development focus. ... and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key ...

Aug, 2014 29 pages
BiOrion Technologies B.V. - Product Pipeline Review - 2014 US$ 1,500.00

... The report reviews current pipeline of BiOrion Technologies B.V.’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the BiOrion Technologies B.V.’s pipeline products ...

Aug, 2014 19 pages
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM US$ 4,995.00

... provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM", which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the ...

Aug, 2014 105 pages
ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations US$ 4,995.00

... Summary GBI Research has released the pharma report, “ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive ... for an additional duration, representing an unmet need within this growing ADHD segment. The current developmental pipeline addresses these gaps in the ...

Jul, 2014 91 pages
Global Antifungal Therapeutics Market:Trends and Opportunities (2014-2019) US$ 800.00

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with ... respective classes. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will ...

Aug, 2014 65 pages
Astraea Therapeutics, LLC - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Astraea Therapeutics, LLC including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Astraea Therapeutics, LLC’s pipeline products Reasons ...

Jul, 2014 18 pages
Global Hodgkins Lymphoma Therapeutics Market 2014-2018 US$ 2,500.00

... treatment for the condition. TechNavio's analysts forecast the Global Hodgkin's Lymphoma Therapeutics market will grow at a CAGR of 6.84 percent over the period ... report also includes a discussion of the Key Vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Bristol Myers ...

Aug, 2014 79 pages
Allergic Asthma-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Allergic Asthma-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Adult Malignant Glioma -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Adult Malignant Glioma -Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Adenovirus Infections-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Adenovirus Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Adenovirus Infections. This report provides ...

Aug, 2014
Acute Spinal Cord Injury-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Spinal Cord Injury-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Acute Ischemic Stroke-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Ischemic Stroke-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Acute Bacterial Sinusitis-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Bacterial Sinusitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Actinic Keratosis-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Actinic Keratosis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Actinic Keratosis. This ...

Aug, 2014
Acne Vulgaris-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acne Vulgaris-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Abscess-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Opsona Therapeutics Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Opsona Therapeutics Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Opsona Therapeutics Ltd.’s pipeline products Reasons to ...

Jul, 2014 25 pages
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Review, H2, 2014' provides data on the Obsessive-Compulsive Disorder clinical trial scenario. This report provides elemental information and data relating ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Jul, 2014 79 pages
Keratitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Keratitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Influenza- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Influenza- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... SUMMARY DelveInsight’s, “ Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Indigestion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Indigestion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Hyperlipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hyperlipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Hypercholesterolemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hypercholesterolemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Hypercalcemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hypercalcemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... Global Sales Figure from 2011-2015. Reasons to buy Evaluate the marketing status and exclusivity details of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer key products to exploit opportunities for generic drug development opportunities. Identify and understand important ...

Jul, 2014
Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
HIV / AIDS- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ HIV / AIDS- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... File (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Herpes Labialis (Oral Herpes)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Herpes Labialis (Oral Herpes)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish ...

Jul, 2014
Hepatitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hepatitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Hemorrhage- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hemorrhage- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Haemophilus Influenzae Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Haemophilus Influenzae Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015 ...

Jul, 2014
Gram-Positive Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gram-Positive Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides ... File (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gram-Negative Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gram-Negative Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides ... File (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gouty Arthritis (Gout)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gouty Arthritis (Gout)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gonorrhea- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gonorrhea- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
General Anesthetic Effect- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ General Anesthetic Effect- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gastric Ulcers- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gastric Ulcers- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Fungal Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Fungal Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Fever- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... SUMMARY DelveInsight’s, “ Fever- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... primary intelligence over active ingredients manufacturers across the globe. API intelligence over leading Phase III pipeline drugs. Develop and ...

Jul, 2014
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... business potential and Scope. Understanding the Scope of the Phase III Drugs with nil regulatory filings. Understanding the chemical route of synthesis of approved drugs for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). Uncovering opportunities in the rapidly growing the US markets.

Jul, 2014
1 2 3 4 5 >
Skip to top